Our group was initially constituted as a multidisciplinary team basically composed of specialists in fetal medicine and children’s cardiologists to continue working in the field of congenital heart disease (CC) research. To this fruitful line of research has been added in recent years related to the prediction, early diagnosis and prognosis of preeclampsia (PE) through the combined use of clinical, sonographic and biochemical markers.
In recent years, the group develops activities in two main lines of research:
Congenital heart defects
The research is mainly focused in the following issues:
Preeclampsia
Here the research is mainly centered in these points:
For all this we currently have a grant from the Carlos III Institute and we collaborate in another multicentre clinical trial also funded by this Institute. Finally, we are part of collaborative international networks that work on the same issue, such as the “The Global Pregnancy Collaboration” (CoLab), and the “Cerebroplacental ratio individual participant data (CPR IPD) metaanalysis”